Insider Transactions in Q2 2023 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,534
+1.09%
|
-
|
|
Jun 30
2023
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,534
+10.41%
|
-
|
|
Jun 30
2023
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,057
-9.3%
|
$0
$0.86 P/Share
|
|
Jun 30
2023
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,841
+24.08%
|
-
|
|
Jun 30
2023
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,269
-8.46%
|
$0
$0.86 P/Share
|
|
Jun 30
2023
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,039
+22.4%
|
-
|
|
Jun 30
2023
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,104
-13.95%
|
$0
$0.86 P/Share
|
|
Jun 30
2023
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,846
+28.87%
|
-
|
|
Jun 30
2023
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,534
+10.86%
|
-
|
|
Jun 30
2023
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,534
+8.94%
|
-
|